| Literature DB >> 17895902 |
Miguel Mitne-Neto1, Fernando Kok, Christian Beetz, André Pessoa, Clarissa Bueno, Zodja Graciani, Marcilia Martyn, Carlos B M Monteiro, Guilherme Mitne, Paulo Hubert, Anders O H Nygren, Marcos Valadares, Antonia M P Cerqueira, Alessandra Starling, Thomas Deufel, Mayana Zatz.
Abstract
SPG4 mutations are the most frequent cause of autosomal-dominant hereditary spastic paraplegia (HSP). SPG4 HSP is characterized by large inter- and intrafamilial variability in age at onset (AAO) and disease severity. The broad spectrum of SPG4 mutations has recently been further extended by the finding of large genomic deletions in SPG4-linked pedigrees negative for 'small' mutations. We had previously reported a very large pedigree, linked to the SPG4 locus with many affected members, which showed gender difference in clinical manifestation. Screening for copy number aberrations revealed the first case of a multi-exonic duplication (exon10_12dup) in the SPG4 gene. The mutation leads to a premature stop codon, suggesting that the protein product is not functional. The analysis of 30 individuals who carry the mutation showed that males have on average an earlier AAO and are more severely affected. The present family suggests that this HSP pathogenesis may be modulated by factors related to individual background and gender as observed for other autosomal dominant conditions, such as facio-scapulohumeral muscular dystrophy or amyloidosis. Understanding why some individuals, particularly women, are 'partially protected' from the effects of this and other pathogenic mutations is of utmost importance.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17895902 DOI: 10.1038/sj.ejhg.5201924
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246